Durable immunotherapeutic response in molecularly complex pulmonary adenosquamous carcinoma: case report and literature review
{{output}}
Pulmonary adenosquamous carcinoma (ASC) is a rare and aggressive subtype of non-small cell lung cancer (NSCLC) with poorly defined molecular characteristics and therapeutic strategies. We present a 63-year-old male patient with stage IVa (cT4N3M1b) lung ASC. N... ...
